160 related articles for article (PubMed ID: 36265005)
1. Association of provider HPV vaccination training with provider assessment of HPV vaccination status and recommendation of HPV vaccination.
Osaghae I; Darkoh C; Chido-Amajuoyi OG; Chan W; Wermuth PP; Pande M; Cunningham SA; Shete S
Hum Vaccin Immunother; 2022 Nov; 18(6):2132755. PubMed ID: 36265005
[TBL] [Abstract][Full Text] [Related]
2. Factors that Influence Healthcare Provider Recommendation of HPV Vaccination.
Btoush R; Kohler RK; Carmody DP; Hudson SV; Tsui J
Am J Health Promot; 2022 Sep; 36(7):1152-1161. PubMed ID: 35442819
[No Abstract] [Full Text] [Related]
3. Human papillomavirus vaccination related knowledge, and recommendations among healthcare providers in Southern China: a cross-sectional survey.
Chen S; Mei C; Huang W; Liu P; Wang H; Lin W; Yuan S; Wang Y
BMC Womens Health; 2022 May; 22(1):169. PubMed ID: 35568870
[TBL] [Abstract][Full Text] [Related]
4. Associations of trust and healthcare provider advice with HPV vaccine acceptance among African American parents.
Fu LY; Zimet GD; Latkin CA; Joseph JG
Vaccine; 2017 Feb; 35(5):802-807. PubMed ID: 28063706
[TBL] [Abstract][Full Text] [Related]
5. A nationwide post-marketing survey of knowledge, attitudes and recommendations towards human papillomavirus vaccines among healthcare providers in China.
Xu X; Wang Y; Liu Y; Yu Y; Yang C; Zhang Y; Hong Y; Wang Y; Zhang X; Bian R; Cao X; Xu L; Hu S; Zhao F
Prev Med; 2021 May; 146():106484. PubMed ID: 33647350
[TBL] [Abstract][Full Text] [Related]
6. HPV Vaccination Training of Healthcare Providers and Perceived Self-Efficacy in HPV Vaccine-Hesitancy Counseling.
Osaghae I; Darkoh C; Chido-Amajuoyi OG; Chan W; Padgett Wermuth P; Pande M; Cunningham SA; Shete S
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560435
[TBL] [Abstract][Full Text] [Related]
7. Barriers to the assessment and recommendation of HPV vaccination among healthcare providers in Texas.
Chido-Amajuoyi OG; Osaghae I; Onyeaka HK; Shete S
Vaccine X; 2024 Jun; 18():100471. PubMed ID: 38523619
[TBL] [Abstract][Full Text] [Related]
8. Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities.
Osaghae I; Chido-Amajuoyi OG; Khalifa BAA; Shete S
Hum Vaccin Immunother; 2023 Aug; 19(2):2264596. PubMed ID: 37846730
[TBL] [Abstract][Full Text] [Related]
9. Frequency of health care provider recommendations for HPV vaccination: a survey in three large cities in China.
Mao Y; Zhao Y; Zhang L; Li J; Abdullah AS; Zheng P; Wang F
Front Public Health; 2023; 11():1203610. PubMed ID: 37497028
[TBL] [Abstract][Full Text] [Related]
10. Provider perspectives on multilevel barriers to HPV vaccination.
Lake PW; Kasting ML; Christy SM; Vadaparampil ST
Hum Vaccin Immunother; 2019; 15(7-8):1784-1793. PubMed ID: 30779687
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Vaccination of Adolescents with Chronic Medical Conditions: A National Survey of Pediatric Subspecialists.
Hofstetter AM; Lappetito L; Stockwell MS; Rosenthal SL
J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):88-95. PubMed ID: 27542999
[TBL] [Abstract][Full Text] [Related]
12. Factors associated with Human Papilloma Virus (HPV) vaccine recommendation by physicians in Lebanon, a cross-sectional study.
Abi Jaoude J; Khair D; Dagher H; Saad H; Cherfan P; Kaafarani MA; Jamaluddine Z; Ghattas H
Vaccine; 2018 Nov; 36(49):7562-7567. PubMed ID: 30420044
[TBL] [Abstract][Full Text] [Related]
13. Provider communication and HPV vaccination: The impact of recommendation quality.
Gilkey MB; Calo WA; Moss JL; Shah PD; Marciniak MW; Brewer NT
Vaccine; 2016 Feb; 34(9):1187-92. PubMed ID: 26812078
[TBL] [Abstract][Full Text] [Related]
14. Predictors of provider recommendation for HPV vaccine among young adult men and women: findings from a cross-sectional survey.
Gerend MA; Shepherd MA; Lustria ML; Shepherd JE
Sex Transm Infect; 2016 Mar; 92(2):104-7. PubMed ID: 26297720
[TBL] [Abstract][Full Text] [Related]
15. Impact of visit characteristics on intention to recommend HPV vaccine: An experiment with US health care professionals.
Kong WY; Queen TL; Gottfredson O'Shea N; Heisler-MacKinnon J; Liu A; Ozawa S; Brewer NT; Gilkey MB
Prev Med; 2024 Feb; 179():107841. PubMed ID: 38160884
[TBL] [Abstract][Full Text] [Related]
16. Association of both consistency and strength of self-reported clinician recommendation for HPV vaccination and HPV vaccine uptake among 11- to 12-year-old children.
Finney Rutten LJ; St Sauver JL; Beebe TJ; Wilson PM; Jacobson DJ; Fan C; Breitkopf CR; Vadaparampil ST; MacLaughlin KL; Jacobson RM
Vaccine; 2017 Oct; 35(45):6122-6128. PubMed ID: 28958810
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus vaccination practices and perceptions among Ghanaian Healthcare Providers: A qualitative study based on multi-theory model.
Agyei-Baffour P; Asare M; Lanning B; Koranteng A; Millan C; Commeh ME; Montealegre JR; Mamudu HM
PLoS One; 2020; 15(10):e0240657. PubMed ID: 33064718
[TBL] [Abstract][Full Text] [Related]
18. Recommending Human Papillomavirus Vaccination at Age 9: A National Survey of Primary Care Professionals.
Kong WY; Huang Q; Thompson P; Grabert BK; Brewer NT; Gilkey MB
Acad Pediatr; 2022; 22(4):573-580. PubMed ID: 35081470
[TBL] [Abstract][Full Text] [Related]
19. UK healthcare professionals' uncertainties, barriers and facilitators to the introduction of targeted human papillomavirus vaccination for men who have sex with men.
Nadarzynski T; Llewellyn C; Richardson D; Pollard A; Smith H
Sex Health; 2017 Aug; 14(4):372-377. PubMed ID: 28591548
[TBL] [Abstract][Full Text] [Related]
20. Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020.
Osaghae I; Chandra M; Talluri R; Shete S
Hum Vaccin Immunother; 2023 Aug; 19(2):2239678. PubMed ID: 37550623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
